Eph-ephrin bidirectional signaling comes into the context of lymphocyte transendothelial migration

References

• Germain RN, Bajenoff M, Castellino F, Chieppa M, Egen JG, Huang AY, et al. Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imaging. Immunol Rev 2008; 221:42 - 45
   Web of Science ®Google Scholar
• Bajenoff M, Egen JG, Qi H, Huang AY, Castellino F, Germain RN. Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node. Trends Immunol 2007; 28:346 - 352
   Google Scholar
• Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005; 6:1182 - 1190
   PubMed Web of Science ®Google Scholar
• Aurrand-Lions M, Johnson-Leger C, Imhof BA. The last molecular fortress in leukocyte trans-endothelial migration. Nat Immunol 2002; 3:116 - 118
   PubMed Web of Science ®Google Scholar
• Rodrigo Mora J, Von Andrian UH. Specificity and plasticity of memory lymphocyte migration. Curr Top Microbiol Immunol 2006; 308:83 - 116
   PubMed Web of Science ®Google Scholar
• Wittchen ES. Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front Biosci 2009; 14:2522 - 2545
   PubMed Web of Science ®Google Scholar
• Muller WA. Mechanisms of transendothelial migration of leukocytes. Circ Res 2009; 105:223 - 230
   PubMed Web of Science ®Google Scholar
• Alon R, Luscinskas FW. Crawling and INTEGRating apical cues. Nat Immunol 2004; 5:351 - 353
   PubMed Web of Science ®Google Scholar
• Dunon D, Piali L, Imhof BA. To stick or not to stick: The new leukocyte homing paradigm. Curr Opin Cell Biol 1996; 8:714 - 723
   PubMed Web of Science ®Google Scholar
• Imhof BA, Aurrand-Lions M. Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 2004; 4:432 - 444
   PubMed Web of Science ®Google Scholar
• Salmi M, Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 2005; 5:760 - 771
   PubMed Web of Science ®Google Scholar
• Huttenlocher A, Poznansky MC. Reverse leukocyte migration can be attractive or repulsive. Trends Cell Biol 2008; 18:298 - 306
   Google Scholar
• Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002; 111:251 - 263
   PubMed Web of Science ®Google Scholar
• Henkemeyer M, Orioli D, Henderson JT, Saxton TM, Roder J, Pawson T, et al. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 1996; 86:35 - 46
   PubMed Web of Science ®Google Scholar
• Lackmann M, Boyd AW. Eph, a protein family coming of age: more confusion, insight or complexity?. Sci Signal 2008; 1:2
   PubMed Web of Science ®Google Scholar
• Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 2005; 6:462 - 475
   PubMed Web of Science ®Google Scholar
• Merlos-Suarez A, Batlle E. Eph-ephrin signalling in adult tissues and cancer. Curr Opin Cell Biol 2008;
   PubMed Web of Science ®Google Scholar
• Pasquale EB. Eph-ephrin bidirectional signaling in physiology and disease. Cell 2008; 133:38 - 52
   PubMed Web of Science ®Google Scholar
• Janes PW, Adikari S, Lackmann M. Eph/ephrin signalling and function in oncogenesis: lessons from embryonic development. Curr Cancer Drug Targets 2008; 8:473 - 479
   PubMed Web of Science ®Google Scholar
• Davy A, Soriano P. Ephrin signaling in vivo: look both ways. Dev Dyn 2005; 232:1 - 10
   PubMed Web of Science ®Google Scholar
• Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M, Pawson T. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 1996; 383:722 - 725
   PubMed Web of Science ®Google Scholar
• Bruckner K, Pasquale EB, Klein R. Tyrosine phosphorylation of transmembrane ligands for Eph receptors. Science 1997; 275:1640 - 1643
   PubMed Web of Science ®Google Scholar
• Davy A, Gale NW, Murray EW, Klinghoffer RA, Soriano P, Feuerstein C, et al. Compartmentalized signaling by GPI-anchored ephrin-A5 requires the Fyn tyrosine kinase to regulate cellular adhesion. Genes & development 1999; 13:3125 - 3135
   PubMed Web of Science ®Google Scholar
• Trinidad EM, Ballesteros M, Zuloaga J, Zapata A, Alonso-Colmenar LM. An impaired transendothelial migration potential of chronic lymphocytic leukemia (CLL) cells can be linked to ephrin-A4 expression. Blood 2009; 114:5081 - 5090
   PubMed Web of Science ®Google Scholar
• Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AL, Pasquale EB. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 2000; 19:6043 - 6052
   PubMed Web of Science ®Google Scholar
• Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE, et al. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 2002; 21:7011 - 7026
   PubMed Web of Science ®Google Scholar
• Larson J, Schomberg S, Schroeder W, Carpenter TC. Endothelial EphA receptor stimulation increases lung vascular permeability. Am J Physiol Lung Cell Mol Physiol 2008; 295:431 - 439
   Web of Science ®Google Scholar
• Chan B, Sukhatme VP. Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro. Thromb Res 2009; 123:745 - 752
   PubMed Web of Science ®Google Scholar
• Ivanov AI, Romanovsky AA. Putative dual role of ephrin-Eph receptor interactions in inflammation. IUBMB Life 2006; 58:389 - 394
   PubMed Web of Science ®Google Scholar
• Sharfe N, Nikolic M, Cimpeon L, Van De Kratts A, Freywald A, Roifman CM. EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions. Mol Immunol 2008; 45:1208 - 1220
   PubMed Web of Science ®Google Scholar
• Alonso CL, Trinidad EM, de Garcillan B, Ballesteros M, Castellanos M, Cotillo I, et al. Expression profile of Eph receptors and ephrin ligands in healthy human B lymphocytes and chronic lymphocytic leukemia B-cells. Leuk Res 2009; 33:395 - 406
   PubMed Web of Science ®Google Scholar
• Carvalho RF, Beutler M, Marler KJ, Knoll B, Becker-Barroso E, Heintzmann R, et al. Silencing of EphA3 through a cis interaction with ephrinA5. Nat Neurosci 2006; 9:322 - 330
   Google Scholar
• Yin Y, Yamashita Y, Noda H, Okafuji T, Go MJ, Tanaka H. EphA receptor tyrosine kinases interact with co-expressed ephrin-A ligands in cis. Neurosci Res 2004; 48:285 - 296
   PubMed Web of Science ®Google Scholar
• Marquardt T, Shirasaki R, Ghosh S, Andrews SE, Carter N, Hunter T, et al. Coexpressed EphA receptors and ephrin-A ligands mediate opposing actions on growth cone navigation from distinct membrane domains. Cell 2005; 121:127 - 139
   PubMed Web of Science ®Google Scholar
• Cinamon G, Grabovsky V, Winter E, Franitza S, Feigelson S, Shamri R, et al. Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow. J Leukoc Biol 2001; 69:860 - 866
   PubMed Web of Science ®Google Scholar
• Grabovsky V, Feigelson S, Chen C, Bleijs DA, Peled A, Cinamon G, et al. Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med 2000; 192:495 - 506
   PubMed Web of Science ®Google Scholar
• Piali L, Weber C, LaRosa G, Mackay CR, Springer TA, Clark-Lewis I, et al. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur J Immunol 1998; 28:961 - 972
   PubMed Web of Science ®Google Scholar
• Shulman Z, Shinder V, Klein E, Grabovsky V, Yeger O, Geron E, et al. Lymphocyte crawling and transendothelial migration require chemokine triggering of high-affinity LFA-1 integrin. Immunity 2009; 30:384 - 396
   PubMed Web of Science ®Google Scholar
• Arvanitis D, Davy A. Eph/ephrin signaling: networks. Genes Dev 2008; 22:416 - 429
   PubMed Web of Science ®Google Scholar
• Himanen JP, Saha N, Nikolov DB. Cell-cell signaling via Eph receptors and ephrins. Curr Opin Cell Biol 2007; 19:534 - 542
   PubMed Web of Science ®Google Scholar
• Poliakov A, Cotrina M, Wilkinson DG. Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell 2004; 7:465 - 480
   PubMedGoogle Scholar
• De Bruyn PP, Cho Y, Michelson S. Endothelial attachment and plasmalemmal apposition in the transcellular movement of intravascular leukemic cells entering the myeloid parenchyma. Am J Anat 1989; 186:115 - 126
   PubMedGoogle Scholar
• Carman CV, Sage PT, Sciuto TE, de la Fuente MA, Geha RS, Ochs HD, et al. Transcellular diapedesis is initiated by invasive podosomes. Immunity 2007; 26:784 - 797
   PubMed Web of Science ®Google Scholar
• Nieminen M, Henttinen T, Merinen M, Marttila-Ichihara F, Eriksson JE, Jalkanen S. Vimentin function in lymphocyte adhesion and transcellular migration. Nat Cell Biol 2006; 8:156 - 162
   PubMed Web of Science ®Google Scholar
• Millan J, Hewlett L, Glyn M, Toomre D, Clark P, Ridley AJ. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nat Cell Biol 2006; 8:113 - 123
   PubMed Web of Science ®Google Scholar
• Miura K, Nam JM, Kojima C, Mochizuki N, Sabe H. EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts. Mol Biol Cell 2009; 20:1949 - 1959
   PubMedGoogle Scholar
• Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE, Hendrix MJ. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther 2006; 5:228 - 233
   PubMed Web of Science ®Google Scholar
• Zantek ND, Azimi M, Fedor-Chaiken M, Wang B, Brackenbury R, Kinch MS. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ 1999; 10:629 - 638
   PubMedGoogle Scholar
• Ghia P, Caligaris-Cappio F. The origin of B-cell chronic lymphocytic leukemia. Semin Oncol 2006; 33:150 - 156
   PubMed Web of Science ®Google Scholar
• Keating MJ, Chiorazzi N, Messmer B, Damle RN, Allen SL, Rai KR, et al. Biology and treatment of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2003; 153 - 175
   PubMedGoogle Scholar
• D'Arena G, Di Renzo N, Brugiatelli M, Vigliotti ML, Keating MJ. Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2003; 44:223 - 228
   PubMed Web of Science ®Google Scholar
• Hamblin T. Chronic lymphocytic leukaemia: One disease or two?. Ann Hematol 2002; 81:299 - 303
   PubMed Web of Science ®Google Scholar
• Stauder R, Hamader S, Fasching B, Kemmler G, Thaler J, Huber H. Adhesion to high endothelial venules: a model for dissemination mechanisms in non-Hodgkin's lymphoma. Blood 1993; 82:262 - 267
   PubMed Web of Science ®Google Scholar
• Chen JR, Gu BJ, Dao LP, Bradley CJ, Mulligan SP, Wiley JS. Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved downregulation of both L-selectin and CD23. Br J Haematol 1999; 105:181 - 189
   PubMed Web of Science ®Google Scholar
• Gu B, Dao LP, Wiley J. Impaired transendothelial migration of B-CLL lymphocytes: A defect linked to low L-selectin expression. Leuk Lymphoma 2001; 42:5 - 12
   PubMed Web of Science ®Google Scholar
• Hartmann TN, Grabovsky V, Wang W, Desch P, Rubenzer G, Wollner S, et al. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow. Cancer Res 2009; 69:3121 - 3130
   PubMed Web of Science ®Google Scholar
• Bazerbashi MB, Reeve J, Chanarin I. Studies in chronic lymphocytic leukaemia. The kinetics of 51Cr-labelled lymphocytes. Scand J Haematol 1978; 20:37 - 51
   PubMedGoogle Scholar
• Dormer P, Theml H, Lau B. Chronic lymphocytic leukemia: A proliferative or accumulative disorder?. Leuk Res 1983; 7:1 - 10
   PubMed Web of Science ®Google Scholar
• Munk Pedersen I, Reed J. Microenvironmental interactions and survival of CLL B-cells. Leuk Lymphoma 2004; 45:2365 - 2372
   PubMed Web of Science ®Google Scholar
• Patten PE, Buggins AG, Richards J, Wotherspoon A, Salisbury J, Mufti GJ, et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood 2008; 111:5173 - 5181
   PubMed Web of Science ®Google Scholar
• Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, Cesar D, et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005; 115:755 - 764
   PubMed Web of Science ®Google Scholar